Healthpeak Q3 2021 Earnings Report
Key Takeaways
Healthpeak Properties reported a net income of $0.10 per share, Nareit FFO of $0.36 per share, FFO as Adjusted of $0.40 per share, and blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 3.2%. The company also announced $782 million of new acquisitions and signed 178,000 square feet of new leases at its active developments.
Net income of $0.10 per share, Nareit FFO of $0.36 per share, FFO as Adjusted of $0.40 per share, and blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 3.2%.
Life Science and MOB Same-Store Portfolio Cash (Adjusted) NOI growth of 6.8% and 2.9%, respectively.
Announced $782 million of new acquisitions.
Signed 178,000 square feet of new leases at our active developments, including 36,000 square feet at The Shore at Sierra Point Phase II, bringing the project to 100% pre-leased, and 142,000 square feet at 101 CambridgePark Drive, bringing the project to 88% pre-leased.
Healthpeak
Healthpeak
Forward Guidance
For full year 2021, we are updating the following guidance ranges:
Positive Outlook
- Diluted Nareit FFO per share from $1.06 – $1.12 to $1.09 – $1.13
- Diluted FFO as Adjusted per share from $1.55 – $1.61 to $1.58 – $1.62
- Blended Total Portfolio Same-Store Cash (Adjusted) NOI growth from 2.25% – 3.75% to 3.50% – 4.00%
Challenges Ahead
- Diluted earnings per common share from $0.95 – $1.01 to $0.94 – $0.98